Databricks Unifies Clinical Data

The perennial problem of clinical trial delays, where nearly half of investigator sites miss enrollment targets, stems not from a lack of tools but from a fundamental architectural flaw: disconnected data. Databricks is aiming to fix this with its new open-source Site Feasibility Workbench, which places clinical operations intelligence directly on its Lakehouse platform.

This approach eliminates the costly integration overhead, credential sprawl, and synchronization lag that plague traditional clinical trial operations. The challenge it solves is stark: 37% of activated sites under-enroll, leading to substantial financial losses and extended timelines, a problem that has persisted for decades. This new solution, detailed on the Databricks blog, argues that clinical teams need decision-support applications to live where their data and models reside.

The Architecture Argument

Conventional systems involve separate data warehouses, operational databases, and web applications, all linked by synchronization pipelines. Each layer introduces delays and erodes data trust. Databricks Apps, Lakebase, and AI/BI Genie are designed to make these intermediary layers obsolete.

Databricks Apps run directly within the workspace, securely accessing data via internal connections. Lakebase acts as a scalable operational database, managed within the Databricks environment. AI/BI Genie provides natural language access to governed data, enabling study managers to query information seamlessly.

This unified stack means clinical data never leaves the workspace boundary, inheriting existing access controls and eliminating the need for external API calls or separate synchronization jobs.

The Auditability Argument

Current site feasibility tools often rely on generic industry data, failing to leverage a sponsor's unique historical performance. The Site Feasibility Workbench trains machine learning models on an organization's own clinical trial data—CTMS, EDC, and IRT history—for more precise predictions.

Models are trained on historical enrollment rates, site qualification data, and protocol execution records, improving as the portfolio grows. MLflow tracks every training run, providing a complete audit trail from raw data to deployed predictions.

Crucially, every prediction includes SHAP attributions stored as governed Delta tables. This ensures the rationale behind site selection is as auditable and versioned as the score itself, addressing regulatory requirements like 21 CFR Part 11 and ICH E6(R3).

This level of transparency allows clinical affairs teams to directly answer questions about model recommendations, moving beyond opaque vendor reports.

What We Built

The Site Feasibility Workbench guides users through protocol selection, geographic analysis, site ranking, and shortlist generation. It incorporates diversity considerations as a core scoring dimension, aligning with regulatory expectations.

Composite scores integrate real-world evidence, patient access data, and historical site performance, all powered by TA-segmented LightGBM models trained on the organization's proprietary data. Patient-level data adheres to the sponsor's HIPAA posture, with PHI handling managed at the catalog or schema level.

The application makes no external API calls and requires no infrastructure outside the Databricks workspace. It serves as a decision-support layer, not a system of record.

This tool is one module of a larger initiative, the Databricks Clinical Operations Intelligence Hub, which aims to cover the full trial lifecycle, including patient cohort building, enrollment optimization, and risk-based monitoring. These applications deploy as Databricks Apps, querying Unity Catalog directly and closing the feedback loop between data, models, and operational outcomes.

The full application, including its FastAPI backend and React frontend, is available as an open-source repository, allowing for deployment into existing Databricks workspaces in approximately 30 minutes.